Welcome to LookChem.com Sign In|Join Free

CAS

  • or

616-01-3

Post Buying Request

616-01-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

616-01-3 Usage

Molecular structure

Long-chain fatty acid with two hydroxyl groups at the 13th and 14th carbon atoms

Primary location

Brain and nervous system

Key component

Sphingolipids

Function in tissues

Maintains structural integrity and function of brain and nervous system tissues

Involvement in lipid synthesis

Plays a role in the synthesis of complex lipids, such as ceramides

Role in cell signaling

Ceramides are crucial for cell signaling and communication

Receptor activation

Potent agonist of peroxisome proliferator-activated receptor alpha (PPARα)

Receptor function

PPARα is a nuclear receptor involved in the regulation of lipid metabolism and inflammation

Therapeutic potential

May have applications in the treatment of metabolic disorders, neurodegenerative diseases, and inflammatory conditions

Check Digit Verification of cas no

The CAS Registry Mumber 616-01-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,1 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 616-01:
(5*6)+(4*1)+(3*6)+(2*0)+(1*1)=53
53 % 10 = 3
So 616-01-3 is a valid CAS Registry Number.
InChI:InChI=1/C22H44O4/c1-2-3-4-5-11-14-17-20(23)21(24)18-15-12-9-7-6-8-10-13-16-19-22(25)26/h20-21,23-24H,2-19H2,1H3,(H,25,26)

616-01-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 13,14-dihydroxydocosanoic acid

1.2 Other means of identification

Product number -
Other names 13,14-dihydroxy-docosanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:616-01-3 SDS

616-01-3Relevant articles and documents

Synthesis of 14C-labeled FAD-C44

Bieniarz, Christopher,Ramakrishna, Kornepati V.,Kelly, Terence P.

, p. 243 - 250 (2000)

Synthesis of 14C-labeled FAD-C44 1 at the tertiary carbon by the dimerization of 14C labeled erucic acid 2 is described. Labeling at the C-14 position of erucic acid is achieved by a convergent approach involving the Wittig coupling

Membrane-interacting properties of the functionalised fatty acid moiety of muraymycin antibiotics

Ries, Oliver,Carnarius, Christian,Steinem, Claudia,Ducho, Christian

, p. 879 - 886 (2015)

Functional insights into bioactive natural products with medicinal potential are often hindered by their structural complexity. We herein report a simplified model system to investigate the functional significance of a structural motif of biologically potent muraymycin antibiotics of the A-series. These compounds have a highly unusual ω-guanidinylated fatty acid moiety, which has been proposed to mediate membrane penetration, thus enabling the interaction of A-series muraymycins with their intracellular target MraY. Our assay was based on a synthetic conjugate of this fatty acid structure with a negatively charged fluorophore lacking membrane permeability. Using this conjugate, immobilised giant unilamellar lipid vesicles and confocal laser scanning fluorescence microscopy, we demonstrated that the attachment of the ω-N-hydroxy-guanidinyl fatty acid unit led to an enhanced uptake of the fluorophore into the vesicles. This represents the first experimental evidence of this unusual structural motif's functional relevance for the parent natural product, which may support the future design of novel muraymycin analogues.

Fe-catalyzed one-pot oxidative cleavage of unsaturated fatty acids into aldehydes with hydrogen peroxide and sodium periodate

Spannring, Peter,Yazerski, Vital,Bruijnincx, Pieter C. A.,Weckhuysen, Bert M.,Klein Gebbink, Robertus J. M.

, p. 15012 - 15018 (2013/11/06)

A one-pot method has been developed for the oxidative cleavage of internal alkenes into aldehydes by using 0.5mol % of the nonheme iron complex [Fe(OTf)2(mix-bpbp)] (bpbp=N,N'-bis(2-picolyl)-2,2'-bipyrrolidine) as catalyst and 1.5equivalents of hydrogen peroxide and 1equivalent of sodium periodate as oxidants. A mixture of diastereomers of the chiral bpbp ligand can be used, thereby omitting the need for resolution of its optically active components. The cleavage reaction can be performed in one pot within 20h and under ambient conditions. Addition of water after the epoxidation, acidification and subsequent pH neutralization are crucial to perform the epoxidation, hydrolysis, and subsequent diol cleavage in one pot. High aldehyde yields can be obtained for the cleavage of internal aliphatic double bonds with cis and trans configuration (86-98 %) and unsaturated fatty acids and esters (69-96 %). Good aldehyde yields are obtained in reactions of trisubstituted and terminal alkenes (62-63 %). The products can be easily isolated by a simple extraction step with an organic solvent. The presented protocol involves a lower catalyst loading than conventional methods based on Ru or Os. Also, hydrogen peroxide can be used as the oxidant in this case, which is often disproportionated by second- and third-row metals. By using only mild oxidants, overoxidation of the aldehyde to the carboxylic acid is prevented. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 616-01-3